zurück Home | Ergebnisse bei Larynx-Tumoren | |
allgemeines | ||
TREMPLIN | Kann durch Chemotherapie oder Targettherapie eine Laryngektomie vermieden werden? | |
ARCON | Comparing accelerated radiotherapy (AR) with accelerated radiotherapy plus carbogen inhalation and nicotinamide (ARCON) in laryngeal cancer. | |
Indu-Tax | Induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation | |
KROG 0201 | Comparing hypofractionation with conventional fractionation radiotherapy for T1–2 glottic squamous cell carcinomas | |
RTOG 91-11 | Comparison of Three Nonsurgical Treatment Strategies To Preserve the Larynx in Patients With Locally Advanced Larynx Cancer. | |
RTOG 95-12 | Hyperfractionation versus standard fractionation for T2N0 vocal cord carcinoma. | |
TREMPLIN | RT-Cisplatin versus RT-Erbitux | |
Quellen |
|
Impressum Zuletzt geändert am 24.11.2013 3:37